BackSpyGlass Pharma Common Stock Overview

SpyGlass Pharma Common Stock Other Liabilities

Latest other liabilities for SGP: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

SpyGlass Pharma Common Stock Other Liabilities History

Loading

SpyGlass Pharma Common Stock vs. peers: Other Liabilities Comparison

Loading

SpyGlass Pharma Common Stock Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SpyGlass Pharma Common Stock (SGP) FAQ

The latest other liabilities for SGP is $0 as of March 2026. Investors often review this figure alongside SpyGlass Pharma Common Stock's historical trend and sector peers before judging valuation or financial health.

A other liabilities figure of $0 for SGP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SGP's other liabilities ($0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack SpyGlass Pharma Common Stock's other liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.